JPS5320511B1 - - Google Patents

Info

Publication number
JPS5320511B1
JPS5320511B1 JP3763772A JP3763772A JPS5320511B1 JP S5320511 B1 JPS5320511 B1 JP S5320511B1 JP 3763772 A JP3763772 A JP 3763772A JP 3763772 A JP3763772 A JP 3763772A JP S5320511 B1 JPS5320511 B1 JP S5320511B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3763772A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5320511B1 publication Critical patent/JPS5320511B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP3763772A 1971-04-16 1972-04-14 Pending JPS5320511B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB963971A GB1407971A (en) 1971-04-16 1971-04-16 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor

Publications (1)

Publication Number Publication Date
JPS5320511B1 true JPS5320511B1 (en) 1978-06-27

Family

ID=9875880

Family Applications (3)

Application Number Title Priority Date Filing Date
JP3763772A Pending JPS5320511B1 (en) 1971-04-16 1972-04-14
JP15503677A Granted JPS5430189A (en) 1971-04-16 1977-12-22 Production of 2*44diaminoo 55benzylpyrimidine derivative
JP15503777A Pending JPS53111083A (en) 1971-04-16 1977-12-22 Method of producing 2*44diaminoo55benzyll pyrimidine derivative

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP15503677A Granted JPS5430189A (en) 1971-04-16 1977-12-22 Production of 2*44diaminoo 55benzylpyrimidine derivative
JP15503777A Pending JPS53111083A (en) 1971-04-16 1977-12-22 Method of producing 2*44diaminoo55benzyll pyrimidine derivative

Country Status (13)

Country Link
JP (3) JPS5320511B1 (en)
AU (1) AU468447B2 (en)
BE (1) BE782153A (en)
CA (1) CA967964A (en)
CH (1) CH565160A5 (en)
CS (1) CS181221B2 (en)
DE (1) DE2218220A1 (en)
DK (1) DK131466B (en)
FR (1) FR2133752B1 (en)
GB (1) GB1407971A (en)
IL (3) IL39218A (en)
NL (1) NL7205043A (en)
SE (1) SE391180B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
FR2502152A1 (en) * 1981-03-20 1982-09-24 Panmedica Laboratoires NOVEL SUBSTITUTED DIAMINO-2,4-BENZYL-5-PYRIMIDINE N2-SOLUBLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING SAME

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1090394A (en) * 1953-03-11 1955-03-30 Wellcome Found Pyrimidine derivatives and their manufacture
FR1459417A (en) * 1964-11-12 1966-04-29 Hoffmann La Roche Process for the preparation of pyrimidine derivatives
FR1518635A (en) * 1965-07-08 1968-03-29 Wellcome Found Process for the preparation of pyrimidine derivatives
GB1261455A (en) * 1969-03-06 1972-01-26 Burroughs Wellcome Co Improvements in or relating to substituted acrylonitriles

Also Published As

Publication number Publication date
NL7205043A (en) 1972-10-18
SE391180B (en) 1977-02-07
CS181221B2 (en) 1978-03-31
IL47921A (en) 1976-10-31
JPS5430189A (en) 1979-03-06
JPS53111083A (en) 1978-09-28
DK131466B (en) 1975-07-21
IL39218A0 (en) 1972-06-28
JPS5422994B2 (en) 1979-08-10
CH565160A5 (en) 1975-08-15
AU4117472A (en) 1973-10-18
DK131466C (en) 1975-12-08
DE2218220A1 (en) 1972-11-02
AU468447B2 (en) 1976-01-15
CA967964A (en) 1975-05-20
FR2133752A1 (en) 1972-12-01
IL39218A (en) 1976-10-31
FR2133752B1 (en) 1975-04-25
BE782153A (en) 1972-10-16
IL47921A0 (en) 1975-11-25
GB1407971A (en) 1975-10-01

Similar Documents

Publication Publication Date Title
ATA136472A (en)
AR196074A1 (en)
DK131466C (en)
AU2658571A (en)
AU2691671A (en)
AU2894671A (en)
AU2485671A (en)
AU2742671A (en)
AU2941471A (en)
AU2684071A (en)
AU2952271A (en)
AU3005371A (en)
AU2564071A (en)
AU2473671A (en)
AU2836771A (en)
AU3038671A (en)
AU2503871A (en)
AU3025871A (en)
AU2577671A (en)
AU2588771A (en)
AU2654071A (en)
AU2456871A (en)
AU2669471A (en)
AU2455871A (en)
AU2684171A (en)